EP3766986

DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS

granted
JurisdiktionEP
Anmeldedatum28. Dez. 2015
Veröffentlichungsdatum01. Juni 2022
Erteilungsdatum01. Juni 2022
Ablaufdatum28. Dez. 2035
Veröffentlichungsnr.EP3766986
Anmeldenr.EP20179648
UPC-Verfahren5

Zusammenfassung

[0001] This disclosure provides, among other things, methods for generating and applying therapeutic interventions. The methods involve, for example, (a) sequencing polynucleotides from cancer cells from a subject; (b) identifying and quantifying somatic mutations in the polynucleotides; (c) developing a profile of tumor heterogeneity in the subject indicating the presence and relative quantity of a plurality of the somatic mutations in the polynucleotides, wherein different relative quantities indicates tumor heterogeneity; and (d) determining a therapeutic intervention for a cancer exhibiting the tumor heterogeneity, wherein the therapeutic intervention is effective against a cancer having the profile of tumor heterogeneity determined.

Anmelder

GUARDANT HEALTH INC [US]

Erfinder

ELTOUKHY HELMY [US]TALASAZ AMIRALI [US]KERMANI BAHRAM GHAFFARZADEH [US]IHUEGBU NNAMDI [US]

Externe Quellen

Klassifikation

IPC-Klassen
C12N 15/11C12Q 1/68C12Q 1/6869G16B 30/00
CPC-Klassen
C12N 15/11C12Q 1/6827C12Q 1/6869C12Q 1/6886G16B 30/00
AI: Life Sciences
warum

Guardant Health tumor-heterogeneity diagnostics — C12N + C12Q + G16B. Life Science.

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren